Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a standard opioid option ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.